MATINAS BIOPHARMA HOLDINGS, INC. Cash
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Cash of $5.74 million as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2023-05-10
- 2023-03-31: Cash $5.74M.
- 2022-12-31: Cash $6.83M.
- 2022-09-30: Cash $11.20M.
| Period end | Cash |
|---|---|
| 2023-03-31 | $5.74M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $6.83M 10-K · filed 2023-03-15 |
| 2022-09-30 | $11.20M 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |